Research, Exploitation and Patenting in the Area of Human Embryonic Stem Cells in Europe – A Case of Concern Causing Inconsistency

Joseph Straus

European Review, 2017, vol. 25, issue 1, 107-120

Abstract: Research on human embryonic stem cells, their exploitation and patenting is a highly controversial issue. This contribution provides for some basic understanding of technologies involved. It discusses ethical issues and legal rules dealing with the research and exploitation of stem cells in Europe. Moreover, it presents and analyses in some detail the statutory provisions of the EU in dealing with the patenting of human embryonic stem cells and the interpretation and application of those rules by the Court of Justice of the European Union. Finally, the resulting inconsistencies of the system as applied are critically analysed and a suggestion how to resolve them offered.

Date: 2017
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.cambridge.org/core/product/identifier/ ... type/journal_article link to article abstract page (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:cup:eurrev:v:25:y:2017:i:01:p:107-120_00

Access Statistics for this article

More articles in European Review from Cambridge University Press Cambridge University Press, UPH, Shaftesbury Road, Cambridge CB2 8BS UK.
Bibliographic data for series maintained by Kirk Stebbing ().